1. Inicio
  2. Julian Esteban Munoz Henao
imagen de marcador de posición

Julian Esteban Munoz Henao

  • Publicaciones
  • Proyectos

Publicaciones

Publicaciones

  • artículos académico
    • Antimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity
      2025-7-1
    • In Vitro Antifungal Activity of Three Synthetic Peptides against Candida auris and Other Candida Species of Medical Importance
      2023-8-1
    • Therapeutic Use of the Antimicrobial Peptide PNR20 to Resolve Disseminated Candidiasis in a Murine Model
      2023-11-28
    • In Vitro Antifungal Activity of LL-37 Analogue Peptides against Candida spp.
      2022
    • Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans - In Silico, In Vitro and In Vivo Approaches.
      2021
    • In Vitro and In Vivo Inhibitory Activity of Limonene against Different Isolates of Candida spp.
      2020
    • Pathogenicity levels of Colombian strains of Candida auris and Brazilian strains of Candida haemulonii species complex in both murine and Galleria mellonella experimental models
      2020
    • Glucosylceramides From Lomentospora prolificans Induce a Differential Production of Cytokines and Increases the Microbicidal Activity of Macrophages
      2019
    • Candida albicans resistence mechanisms, tools for its analysis
      2018
    • Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis
      2008

  • capítulos
    • Enfermedades infecciosas
      2022-3-10

  • contribuciones en conferencias
    • Actividad antifúngica del péptido PNR20 contra Candida spp.
      2023-11-17
    • Antimicrobial peptides from the Coleoptera family Scarabaeidae against Candida and Cryptococcus pathogenic yeasts.
      2022
    • Synergism In vitro study of peptides derived from human cathelicidin LL-37 associated with fluconazole against different species of Candida.
      2021
    • In vitro study about the antifungal activity of peptides derived from human cathelicidin LL-37, against different strains of Candida spp.
      2021
    • Development and evaluation of antimicrobial peptides from the Scarabaeidae coleopteran family against pathogenic yeasts with public health impact.
      2021-10-10
    • Actividad antifúngica in vitro de péptidos análogos derivados de LL-37 contra levaduras del género Candida
      2020
    • Biofilm formation analysis of c. albicans isolates that cause recurrent vulvovaginal candidiasis from a clinical reference laboratory in Bogotá D.C.
      2019

  • documento
    • Inhibitory activity of limonene against isolated virulent for Candida albicans in vitro and in vivo
      2020

    • Proyectos

    Investigador Principal

  • Evaluación de la capacidad anti fúngica de péptidos sintéticos antibacterianos contra aislamientos clínicos de la levadura emergente, multirresistente Candida auris recuperados en Colombia y otras especies de Cándida de importancia en salud pública. 2020-11-06 - 2023-11-06

    • Coinvestigador

  • Candidiasis vulvovaginal recurrente: estudio de las características clínicas y epidemiológicas, y factores inmunológicos, genéticos y microbiológicos, y su relación con la microbiota vaginal en una cohorte de pacientes colombianas 2021-04-08 - 2023-04-08
  • Desarrollo de péptidos antimicrobianos a partir de péptidos de defensa del hospedero (HDPs) de coleópteros de la familia Scarabaeidae y su evaluación frente a microorganismos causantes de infecciones asociadas a la atención en salud. 2020-01-30 - 2023-01-30

    • Mejore su perfil